Cephalon launches another Treanda action

01-05-2014

Cephalon has filed another lawsuit to protect its chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma treatment Treanda (bendamustine hydrochloride), this time against Canadian pharmaceutical company Uman Pharma.


Cephalon, Uman, Treanda, Teva, ANDA

LSIPR